Research & Education
CURE Expert Connections
CURE Speaking Out
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
See all >
Acute Myeloid Leukemia
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
See all >
AWARD PROGRAM: Extraordinary Healer
AWARD PROGRAM: Ovarian Cancer Heroes
EDUCATED PATIENT SUMMIT: Lung Cancer
AWARD PROGRAM: Lung Cancer Heroes
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Cancer Related Clinical Care of Sexual and Fender Minorities
Ulrike Boehmer, PhD
Sexual and gender minorities are not receiving the same standard of clinical care as other patients with cancer.
Understanding The Relationship Between HPV and Anal Cancer
National LGBT Cancer Network
HPV and Anal cancer are associated with one another, here's what you need to know.
Friday Frontline: June 7, 2019
From today’s top entertainers to racial disparities in access to pain treatment, here’s what is making headlines in the cancer space this week.
FDA Approves Age Expansion of HPV Vaccine
The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.
Driving Research in Rare Cancers
MIKE HENNESSY, SR.
Research continues to drive the oncology field.
Down to the Almighty Dollar: Socioeconomic Status Can Affect Cancer Outcomes
A recent study found that socioeconomic status can play a role in survival for patients with anal cancer.
NCCN Establishes Guidelines for Treating People With HIV and Cancer
Treatment of HIV has drastically improved since the 1980s, but many of these individuals are still facing barriers to proper cancer care.
Immunotherapy Treatment Advances in Anal Cancer
More personalized approaches are being developed to treat patients with metastatic disease.
Despite Benefits, HPV Vaccination Rates Remain Too Low
Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.
Opdivo Is Promising for Advanced Anal Cancer, Study Shows
The PD-1 inhibitor, Opdivo, may be a promising option for patients with advanced anal cancer, according to a recent study.
Not a member?
Sign up now!
Continue without login